From a chance pageant win to starring in international blockbusters, Fala Chen's journey is a testament to her talent and ...

TVB, the trade association of America’s local broadcast television industry, has released a study highlighting the importance ...

Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025 Denifanstat received Breakthrough Therapy designation from FDA for MASH Clearance of Investigation ...

Try Now>> See the top stocks recommended by analysts Sagimet Biosciences NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025 Denifanstat received ...

The hope is a win-win with fledgling talent in the Asian diaspora gaining global exposure, and Asia-based productions getting ...

With movie stars in their first TV roles and cinematic camerawork, the show marked a new era for Hong Kong TV when it premiered 50 years ago.

Sagimet Biosciences Inc. has obtained IND clearance from the FDA for TVB-3567 (ASC-60), a selective small-molecule fatty acid ...

12 Mar - Kayee Tam surprised many recently when she announced that she is leaving TVB.

Linear television remains the most important influence — by far — among a variety of different media platforms, through all stages of consumers’ purchase decision process. That's the key conclusion ...

TVB-3567 is the Company's second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 SAN MATEO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences ...

Sagimet Biosciences (SGMT) announced the clearance of its Investigational New Drug, IND, application for TVB-3567, the Company’s second fatty ...